Aktionsplan Chugai Pharmaceutical Co., Ltd.
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. weitere details| Industry | Pharmaceuticals |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | jpy |
| Див.доход ао | 3.38 |
| Дивиденд ао | 1.13 |
| Сайт | https://www.chugai-pharm.co.jp |
| Цена ао | 49.11 |
| Preisänderung pro Tag: | 0% (44.23) |
|---|---|
| Preisänderung pro Woche: | +1.24% (43.69) |
| Preisänderung pro Monat: | -14.28% (51.6) |
| Preisänderung über 3 Monate: | +3.73% (42.64) |
| Preisänderung über sechs Monate: | -7.47% (47.8) |
| Preisänderung pro Jahr: | +13% (39.14) |
| Preisänderung seit Jahresbeginn: | +0.6371% (43.95) |
|
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
|||||||||||||||||||||||||||||||||||||
| Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
|---|---|---|---|
| Dr. Osamu Okuda | President, CEO & Chairman | 1.44M | 1963 (62 Jahr) |
| Toshiya Sasai | Executive of Investor Relations Group & Corporate Communications Department | N/A | |
| Mr. Shinji Hidaka | Executive Vice President | N/A | |
| Mr. Junichi Ebihara | Executive Vice President | N/A | |
| Dr. Yoshiaki Ohashi | Senior VP & Full-time Audit Supervisory Board Member | N/A | 1960 (65 Jahre) |
| Mr. Tetsuya Yamaguchi | Executive VP & Head of PHC Solution Unit | N/A | |
| Mr. Yoshiyuki Yano | Executive Vice President | N/A | |
| Mr. Iwaaki Taniguchi | Executive VP, Head of Finance Supervisory Division, CFO & Director | 1967 (58 Jahre) | |
| Mr. Masayoshi Higuchi | VP and Head of Quality, Regulatory Compliance Unit, Business Strategy & Compliance Dept. | ||
| Junichi Takano | Head of Marketing & Sales Division |
Adresse: Japan, Chuo, 2-1-1 Nihonbashi-Muromachi - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.chugai-pharm.co.jp
Webseite: https://www.chugai-pharm.co.jp
